Clinical case report: Treatment of a central retinal vein occlusion with hyperbaric oxygen

Undersea and Hyperbaric Medicine

Volumn 34, Issue 5, 2007, Pages 315-319

  Wright, J K ^a   Franklin, B ^b   Zant, E ^c  

^a USAF   (United States)

^b Medical Group   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HUMAN; HYPERBARIC OXYGEN; MALE; METHODOLOGY; RETINA VEIN OCCLUSION;

ADULT; HUMANS; HYPERBARIC OXYGENATION; MALE; RETINAL VEIN OCCLUSION;

EID: 38449101039     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology. 1983;90:458-74.
2. Bearelly S,Fekrat S. Controversy in the management of retinal venous occlusive disease. Int Ophthalmol Clin. 2004;44:85-102.
3. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology. 1998;105:412-6.
4. Central Retinal Vein Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115:486-91.
5. Sharma A, D'Amico DJ. Medical and surgical management of central retinal vein occlusion. Int Ophthalmol Clin. 2004;44:1-16.
6. Jampol LM, Fleischman JA. Central retinal-vein occlusion five days after a marathon. N Engl J Med. 1981;305:764.
7. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005;24:493-519.
8. Gatzonis S, Charakidas A, Polychronopoulou Z, Brouzas D. Unilateral Visual Loss Following Bodybuilding Training. Clin J Sport Med 2004;14:317-318.
9. Gumus K, Kadayifcilar S, Eldem B, Saracbasi O, Ozcebe O, Dundar S, Kirazli Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion? S. Clin Experiment Ophthalmol. 2006;34:305-11.
10. Sperduto RD, Hiller R, Chew E, et al. Risk factors for hemiretinal vein occlusion: Comparison with risk factors for central and branch retinal vein occlusion: The eye disease case-control study. Ophthalmology. 1998;105:765-771.
11. Sharma A, D'Amico DJ. Medical and surgical management of central retinal vein occlusion. Int Ophthalmol Clin. 2004;44:1-16.
12. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology. 1983 90:458-74.
13. Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology. 1979;86:1931-1942.
14. Bertolaccini ML, Hughes GR, Khamashta MA. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. Clin Lab. 2004;50:653-65.
15. A randomized clinical trial of early panretinal photocoagulationfor ischemiccentralvein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology. 1995;102:1434-1444.
16. Browning, DJ, Antoszyk AN. Laser chorioretinal venous anastomosis for nonischemiccentral retinal vein occlusion. Ophthalmology. 1998;105:670-677;discussion 677-679.
17. Kohner EM, Pettit JE, Hamilton AM, et al. Streptokinase in central retinal vein occlusion:A controlled clinical trial. Br Med J. 1976;1:550-553.
18. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108:2249-2257.
19. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases. Retina. 2001;21:408-415.
20. Aggermann T, Stolba U, Brunner S, Binder S. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection. Ophthalmologica. 2006;220:131-3.
21. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE, Borkowski LM. Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases. Retina. 2006;26:306-13.
22. BeiranI, GoldenbergI, AdirY, et al. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol 2001;11:345-50.
23. Miyamoto H, Ogura Y, Wakano Y, Honda Y. [The long term results of hyperbaric oxygen treatment for macular edema with retinal vein occlusion] [Japanese] Nippon Ganka GakkaiZasshi. 1993;97:1065-9.
24. Roy M, Bartow W, Ambrus J, Fauci A, Collier B, Titus J. Retinal leakage in retinal vein occlusion: reduction after hyperbaric oxygen. Ophthalmologica. 1989;198:78-83.
25. Kiryu J, Ogura Y. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica. 1996;210:168-70.
26. Xu YN, Huang JG. [Hyperbaric oxygen treatment for cystoid macular edema secondary to retinal vein occlusion] [Chinese] Zhonghua Yan Ke Za Zhi. 1991;27:216-8.
27. Krott R, Heller R, Aisenbrey S, Bartz-Schmidt KU. Adjunctive hyperbaric oxygenation in macular edema of vascular origin. Undersea Hyperb Med. 2000;27:195-204.
28. Johnson GR Cases from the aerospace medicine residents' teaching file. Case #38. A navigator with nonischemic central retinal vein occlusion progressing to ischemic central retinal vein occlusion. Aviat Space Environ Med. 1990;61:962-5.
29. Vucetic M, Jensen PK, Jansen EC. Diameter variations of retinal blood vessels during and after treatment with hyperbaric oxygen. Br J Ophthalmol. 2004;88:771-5.
30. Benson RM, Minter LM, Osborne BA, Granowitz EV. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol. 2003;1